Literature DB >> 15322207

Regulation of found in inflammatory zone 1 expression in bleomycin-induced lung fibrosis: role of IL-4/IL-13 and mediation via STAT-6.

Tianju Liu1, Hong Jin, Matthew Ullenbruch, Biao Hu, Naozumi Hashimoto, Bethany Moore, Andrew McKenzie, Nicholas W Lukacs, Sem H Phan.   

Abstract

Found in inflammatory zone (FIZZ)1, also known as resistin-like molecule alpha, belongs to a novel class of cysteine-rich secreted protein family, named FIZZ/resistin-like molecule, with unique tissue expression patterns. FIZZ1 is induced in alveolar type II epithelial cells (AECs) in bleomycin (BLM)-induced lung fibrosis, and found to induce myofibroblast differentiation in vitro. The objective of this study was to elucidate the regulation of AEC FIZZ1 expression in pulmonary fibrosis. AECs were isolated from rat lungs and the effects of a number of cytokines on FIZZ1 expression were evaluated by RT-PCR. Of all cytokines examined, only IL-4 and IL-13 were effective in stimulating FIZZ1 expression in AECs. Stimulation by IL-4/IL-13 was accompanied by increases in phosphorylated STAT6 and JAK1. FIZZ1 expression was also stimulated by transfection with a STAT6 expression plasmid, but was inhibited by antisense oligonucleotides directed against STAT6. In vivo studies showed that compared with wild-type controls, both IL-4- and IL-13-deficient mice showed reduced BLM-induced lung FIZZ1 expression and fibrosis, which were essentially abolished in IL-4 and IL-13 doubly deficient mice. Furthermore, STAT6-deficient mice showed marked reduction in BLM-induced lung FIZZ1 expression. Thus, IL-4 and IL-13 are potent inducers of AEC FIZZ1 expression via STAT6 and play key roles in BLM-induced lung FIZZ1 expression and fibrosis. This represents a potential mechanism by which IL-4/IL-13 could play a role in the pathogenesis of lung fibrosis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15322207     DOI: 10.4049/jimmunol.173.5.3425

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  81 in total

1.  Repetitive intradermal bleomycin injections evoke T-helper cell 2 cytokine-driven pulmonary fibrosis.

Authors:  Brijendra Singh; Rajesh K Kasam; Vishwaraj Sontake; Thomas A Wynn; Satish K Madala
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-08-03       Impact factor: 5.464

2.  Alternaria induces STAT6-dependent acute airway eosinophilia and epithelial FIZZ1 expression that promotes airway fibrosis and epithelial thickness.

Authors:  Taylor A Doherty; Naseem Khorram; Kotaro Sugimoto; Dean Sheppard; Peter Rosenthal; Jae Youn Cho; Alexa Pham; Marina Miller; Michael Croft; David H Broide
Journal:  J Immunol       Date:  2012-02-10       Impact factor: 5.422

Review 3.  Novel effector molecules in type 2 inflammation: lessons drawn from helminth infection and allergy.

Authors:  Meera G Nair; Katherine J Guild; David Artis
Journal:  J Immunol       Date:  2006-08-01       Impact factor: 5.422

Review 4.  New weapons in the war on worms: identification of putative mechanisms of immune-mediated expulsion of gastrointestinal nematodes.

Authors:  David Artis
Journal:  Int J Parasitol       Date:  2006-03-13       Impact factor: 3.981

5.  Epigenetic regulation of the alternatively activated macrophage phenotype.

Authors:  Makoto Ishii; Haitao Wen; Callie A S Corsa; Tianju Liu; Ana L Coelho; Ronald M Allen; William F Carson; Karen A Cavassani; Xiangzhi Li; Nicholas W Lukacs; Cory M Hogaboam; Yali Dou; Steven L Kunkel
Journal:  Blood       Date:  2009-06-30       Impact factor: 22.113

Review 6.  Interstitial lung disease in systemic sclerosis: current and future treatment.

Authors:  Roberto Giacomelli; Vasiliki Liakouli; Onorina Berardicurti; Piero Ruscitti; Paola Di Benedetto; Francesco Carubbi; Giuliana Guggino; Salvatore Di Bartolomeo; Francesco Ciccia; Giovanni Triolo; Paola Cipriani
Journal:  Rheumatol Int       Date:  2017-01-06       Impact factor: 2.631

7.  Hierarchical control of interleukin 13 (IL-13) signals in lung fibroblasts by STAT6 and SOX11.

Authors:  Yasutaka Mitamura; Satoshi Nunomura; Yasuhiro Nanri; Kazuhiko Arima; Tomohito Yoshihara; Kosaku Komiya; Shogo Fukuda; Hiroaki Takatori; Hiroshi Nakajima; Masutaka Furue; Kenji Izuhara
Journal:  J Biol Chem       Date:  2018-08-03       Impact factor: 5.157

8.  Serum amyloid P therapeutically attenuates murine bleomycin-induced pulmonary fibrosis via its effects on macrophages.

Authors:  Lynne A Murray; Rogerio Rosada; Ana Paula Moreira; Amrita Joshi; Michael S Kramer; David P Hesson; Rochelle L Argentieri; Susan Mathai; Mridu Gulati; Erica L Herzog; Cory M Hogaboam
Journal:  PLoS One       Date:  2010-03-12       Impact factor: 3.240

9.  Protective effect of geranylgeranylacetone, an inducer of heat shock protein 70, against drug-induced lung injury/fibrosis in an animal model.

Authors:  Takayoshi Fujibayashi; Naozumi Hashimoto; Mayumi Jijiwa; Yoshinori Hasegawa; Toshihisa Kojima; Naoki Ishiguro
Journal:  BMC Pulm Med       Date:  2009-09-16       Impact factor: 3.317

10.  Alternatively activated macrophage-derived RELM-{alpha} is a negative regulator of type 2 inflammation in the lung.

Authors:  Meera G Nair; Yurong Du; Jacqueline G Perrigoue; Colby Zaph; Justin J Taylor; Michael Goldschmidt; Gary P Swain; George D Yancopoulos; David M Valenzuela; Andrew Murphy; Margaret Karow; Sean Stevens; Edward J Pearce; David Artis
Journal:  J Exp Med       Date:  2009-04-06       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.